Anthropic is operating a lab that conducts biology experiments

The company bought stealth AI biotech Coefficient Bio in April, the report says. Anthropic declined to say what the wet lab is working on, apart from stating that it is not focused on drug discovery, and has not described the experiments it conducts. The report describes the facility as a wet lab.

According to the report, the acquisition took place in April of this year and Anthropic now operates a wet lab as a result. The report states that the company would not describe the lab's work beyond the drug discovery exclusion. The company's public statement on the lab's work is limited to that single exclusion. It provides no further detail on the focus of the lab's experiments or on Coefficient Bio's operations before the acquisition.

The report notes that the news of the lab lands amid intense scrutiny of AI safety. It cites, as context, the resignation of Anthropic researcher Jacob Coxon. It also cites a post by Anthropic chief executive Dario Amodei calling on the industry to slow down and self-regulate. The report does not state what prompted Coxon's resignation or when Amodei's post was published. It also does not say whether the biology lab is connected to either development, or what the scrutiny means for the company going forward.